Skip to main content

Ovarian Cancer Scientific Board

Ovarian Cancer Scientific Board

  • Aghajanian 2017

    Carol Aghajanian, MD

    Chief, Gynecologic Medical Oncology Service, Director, MSK NCI Network Program, Avon Chair in Gynecologic Oncology Research, & Member, Memorial Sloan Kettering Cancer Center; Professor of Medicine, Weill Cornell Medicine Visit website
  • JRCR pic

    Juan Cubillos-Ruiz, PhD

    The William J. Ledger, M.D., Distinguished Associate Professor for Infection and Immunology, Department of Obstetrics and Gynecology, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine – Cornell University Visit website
  • Diaz Luis

    Luis A. Diaz, MD

    Head, Division of Solid Tumor Oncology, Grayer Family Chair, Department of Medicine, Memorial Sloan Kettering Cancer Center Visit website
  • Drapkin.Ron arms crossed 2015

    Ronny Drapkin, MD, PhD

    Director, Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Director of Gynecologic Cancer Research, Basser Center for BRCA & Co-Director, Ovarian Cancer Translational Center of Excellence, Abramson Cancer Center at Penn Medicine Visit website
  • Olivier Elemento new 2025

    Olivier Elemento, PhD

    Director, Englander Institute for Precision Medicine, Associate Director, Institute for Computational Biomedicine, Associate Director, Clinical & Translational Science Center, Weill Cornell Medicine Visit website
  • MaryLynne Hedley

    Mary Lynne, Hedley, PhD

    Senior Scientific Fellow, The Broad Institute of MIT & Harvard; Venture Partner, Third Rock Ventures Visit website
  • Lyden

    David C. Lyden, MD, PhD

    Stavros S. Niarchos Professor in Pediatrics and Cell and Developmental Biology, Weill Cornell Medicine; Pediatric Neuro-oncology Attending, Memorial Sloan Kettering Cancer Center Visit website
  • Sabatini

    David M. Sabatini, MD, PhD

    Sr. Group Leader, Prague & Boston, IOCB (Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences) Visit website
  • Sadelain

    Michel Sadelain, MD, PhD

    Director, Columbia Initiative in Cell Engineering and Therapy, Director, Cancer Cell Therapy Initiative, Herbert Irving Comprehensive Cancer Center, Columbia University Visit website
  • Shih headshot

    Ie-Ming Shih, MD, PhD

    Richard W. TeLinde Distinguished Professor, Department of Gynecology and Obstetrics; Co-Director, Women's Malignancies Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine Visit website
  • Tuveson

    David Tuveson, MD, PhD

    Roy J. Zuckerberg Professor of Cancer Therapeutics, Director, Cancer Center, Cold Spring Harbor Laboratory; Chief Scientist, Lustgarten Foundation Visit website
  • Dmitriy Zamarin

    Dmitriy Zamarin, MD, PhD

    Professor, Hematology/Oncology, Section Head, Gynecologic Medical Oncology, Co-Director, Center of Excellence for Gynecologic Cancers, Precision Immunology Institute Icahn Genomics Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai Visit website
  • Zivanovic headshot

    Oliver Zivanovic, MD

    Chairman, Women‘s Hospital, Heidelberg University Visit website